Filing Details
- Accession Number:
- 0001601485-21-000013
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-04-20 17:19:56
- Reporting Period:
- 2021-04-19
- Accepted Time:
- 2021-04-20 17:19:56
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1601485 | Angion Biomedica Corp. | ANGN | Pharmaceutical Preparations (2834) | 113430072 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1640447 | F. John Neylan | C/O Angion Biomedica Corp. 51 Charles Lindbergh Blvd. Uniondale NY 11553 | See Remarks | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-04-19 | 381 | $13.55 | 38,092 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The shares reported in this Form 4 were sold pursuant to a 10b5-1 trading plan adopted by the reporting person solely to satisfy tax or other government withholding obligations in connection with the vesting of shares of Restricted Stock of the Issuer.
Billionaire Hedge Funds
